LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
公司代码LMAT
公司名称LeMaitre Vascular Inc
上市日期Oct 19, 2006
CEOLemaitre (George W)
员工数量651
证券类型Ordinary Share
年结日Oct 19
公司地址63 2nd Ave
城市BURLINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编01803
电话17812212266
网址https://www.lemaitre.com/
公司代码LMAT
上市日期Oct 19, 2006
CEOLemaitre (George W)